Efficacy and Safety of Risankizumab in Crohn's Disease: A Systematic Review and Meta-Analysis of Randomized Trials and Real-World Evidence.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Risankizumab in Crohn's Disease: A Systematic Review and Meta-Analysis of Randomized Trials and Real-World Evidence.
Authors: Abouelmagd AA; Faculty of Medicine, South Valley University, Qena, Egypt. Alaa.AbdRabbo@med.svu.edu.eg., Yassin MN; Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt., Abo-Elnour DE; Faculty of Medicine, Zagazig University, Zagazig, Egypt., Aboelkhier MM; Master- Program, Faculty of Science Cairo University, Cairo, Egypt., Hamam NG; Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt., Elareef AA; Faculty of Medicine, Alexandria University, Alexandria, Egypt., Sayed MS; Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt., Gado MI; Faculty of Medicine, Mansoura University, Mansoura, Egypt., Elqadi TM; Faculty of Medicine, Alexandria University, Alexandria, Egypt., Elazab A; Faculty of Medicine, South Valley University, Qena, Egypt., Mousa YM; Faculty of Medicine, South Valley University, Qena, Egypt., Gabra MD; Faculty of Medicine, South Valley University, Qena, Egypt., Verstockt B; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Louvain, Belgium.; Department of Chronic Diseases and Metabolism, Translational Research Center for Gastrointestinal Disorders [TARGID], Louvain, Belgium.
Source: Digestive diseases and sciences [Dig Dis Sci] 2026 May 18. Date of Electronic Publication: 2026 May 18.
Publication Type: Journal Article
Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-2568
DOI:10.1007/s10620-026-09965-9